Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Essentials of Menopause Management [[electronic resource] ] : A Case-Based Approach / / edited by Lubna Pal, Raja A. Sayegh
| Essentials of Menopause Management [[electronic resource] ] : A Case-Based Approach / / edited by Lubna Pal, Raja A. Sayegh |
| Edizione | [1st ed. 2017.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2017 |
| Descrizione fisica | 1 online resource (XII, 330 p. 22 illus., 15 illus. in color.) |
| Disciplina | 612.6 |
| Soggetto topico |
Reproductive medicine
Gynecology Endocrinology Reproductive Medicine Gynecology Endocrinology |
| ISBN | 3-319-42451-3 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Part I: Symptomatology, epidemiology and impact of the menopausal burden, and review of evidence on the efficacy, risks and benefits of pharmacological and alternative therapies -- Reproductive Aging: Epidemiology, Symptomatology and Nomenclature -- Five Decades of Hormone Therapy Research: The Long, The Short and The Inconclusive -- Non-Hormonal Pharmacotherapies for Menopause Management -- Pharmacotherapies for Menopause Management: Hormonal options -- Management of Menopause and Perimenopause: Integrative Medicine in Support of Wellness -- Part II: An inferential and individualized approach to management of common menopausal concerns through clinical vignettes -- Clinical Management of Menopause-Related Sleep Disturbance -- Management of Genitourinary Syndrome of Menopause (GSM) in menopausal women -- Skeletal Fragility-a Common Menopausal Burden. Risk assessment, diagnosis and management -- Sexuality, Sexual dysfunction and Menopause -- The Case for Androgens in Menopause Management: When and how?- Post-Menopausal Alopecia (Hair Loss) -- Evaluation and Management of Hirsutism in Postmenopausal Women -- Primary Ovarian Insufficiency/Premature Ovarian Failure: Management Considerations and Strategies -- Surgical Menopause -- Vasomotor Symptoms & Medical Disorders -- Part III: Managing Menopause in Cancer Survivors -- Pharmacological Therapy for Vasomotor Symptoms in Breast Cancer Survivors -- Management of Osteoporosis in Postmenopausal Breast Cancer Survivors -- Management Strategies for Sexual Health after Breast Cancer Diagnosis -- Hormonal Therapy for Menopausal Symptoms in Gynecologic Cancer Survivors. |
| Record Nr. | UNINA-9910163029503321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2017 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Polycystic ovary syndrome : current and emerging concepts / / edited by Lubna Pal, David B. Seifer
| Polycystic ovary syndrome : current and emerging concepts / / edited by Lubna Pal, David B. Seifer |
| Edizione | [2nd ed.] |
| Pubbl/distr/stampa | Cham, Switzerland : , : Springer, , [2022] |
| Descrizione fisica | 1 online resource (580 pages) |
| Disciplina | 618.11 |
| Soggetto topico | Polycystic ovary syndrome |
| ISBN | 3-030-92589-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Intro -- Preface -- Acknowledgments -- Contents -- Contributors -- Part I: Epidemiology of Polycystic Ovary Syndrome -- 1: Diagnostic Criteria and Epidemiology of PCOS -- Diagnostic Criteria for Polycystic Ovary Syndrome -- Prevalence of Polycystic Ovary Syndrome: Regional and Ethnic Variation -- Summary -- References -- 2: Prevalence, Presentation, and Diagnosis of PCOS in Adolescents -- Introduction -- Prevalence of PCOS in Adolescence -- Diagnosis of PCOS in Adolescence -- NIH Criteria Applied to Adolescents -- Ovulatory Dysfunction -- Hyperandrogenism -- Pelvic Ultrasound Evaluation -- Comorbidities of PCOS -- Non-alcoholic Fatty Liver Disease -- Prediabetes and Diabetes -- Mood Disorder -- Summary -- References -- 3: Polycystic Ovarian Syndrome: A Diagnosis of Exclusion -- Introduction -- Prevalence and Epidemiology of PCOS -- Diagnostic Criteria for PCOS (Clinical Manifestations, Laboratory, and Imaging) -- Congenital Adrenal Hyperplasia -- Androgen-Secreting Tumors -- Cushing's Syndrome -- Exogenous Androgens -- Idiopathic Hyperandrogenism -- Abnormal Thyroid Functioning -- Hyperprolactinemia -- Functional Hypothalamic Amenorrhea (FHA) -- Hyperandrogenic Insulin Resistance with Acanthosis Nigricans (HAIR-AN) Syndrome -- Hyperreactio Luteinalis -- Summary -- References -- Part II: Pathophysiology, Endocrine, and Metabolic Milieus of Polycystic Ovary Syndrome -- 4: Recent Advances in the Genetics of Polycystic Ovary Syndrome -- The Heritable Basis of PCOS -- Candidate Gene Approaches Revealed an Incomplete Understanding of PCOS Biology -- GWAS Studies in PCOS -- Polygenic Risk Scores for Disease Risk Prediction in PCOS -- Mendelian Randomization Using GWAS Signals -- Identifying Causal Genes at PCOS Risk Loci -- Conclusion and Future Directions -- References -- 5: The Hypothalamic-Pituitary Axis in PCOS -- Introduction.
Normal Female Reproduction -- Neuroendocrine Function -- Gonadal Feedback on the Neuroendocrine System -- Neuroendocrine Abnormalities in PCOS -- Hypersecretion of LH -- Relative FSH Deficiency -- Importance of the Abnormal Gonadotropin Environment in PCOS -- The Role of Obesity in Gonadotropin Secretion in PCOS -- Summary -- Mechanisms Underlying Neuroendocrine Dysfunction in PCOS -- Dysfunctional Control of GnRH Neuronal Secretion -- Kisspeptin, Neurokinin B and Dynorphin (KNDy) and Gamma-Aminobutyric Acidergic (GABAergic) Neurons -- Hyperandrogenemia -- Hyperinsulinemia -- Progesterone Negative Feedback in PCOS: The Effects of Androgens and Insulin -- Anti-Müllerian Hormone (AMH) -- Leptin and Ghrelin -- Summary -- Dysfunctional Control of Pituitary Secretion of LH and FSH -- GnRH Pulse Frequency -- Estrogens and Androgens -- Insulin -- Potential Mediators Underlying the Inhibitory Effect of BMI on LH Secretion -- Summary -- Genetic Evidence of the Complex Pathophysiology of PCOS -- Conclusions -- References -- 6: Ovarian Dysfunction in Polycystic Ovary Syndrome (PCOS) -- Introduction -- Development of the Polycystic Ovary -- At Which Stage Do Follicle Numbers Increase? -- What Might Be Causing These Changes? -- Role of Androgens -- Role of TGFβ Family Members -- Theca and Granulosa Cell Dysfunction in PCOS -- Anovulation -- Ovulatory Versus Anovulatory PCO -- Role of Gonadotrophins -- Insulin Resistance -- Anti-Müllerian Hormone -- Role of Glucocorticoids -- Energy Balance -- Oocyte of PCO -- Summary -- References -- 7: The Role of the Adrenal Glands in the Hyperandrogenism Associated with the Polycystic Ovarian Syndrome -- Adrenal Androgens and PCOS -- The Role of the Adrenal in Childhood and Subsequent Development of PCOS -- Adults with PCOS and the Role of Adrenal Androgens. Adrenal Androgens in Perimenopausal and Postmenopausal Women with PCOS -- Conclusion -- References -- 8: Insulin Resistance and Lipotoxicity in PCOS: Causes and Consequences -- Introduction -- Reminders Concerning Insulin Resistance -- Definitions of Insulin Resistance -- Evolution of Insulin Resistance Knowledge in PCOS -- Insulin and Hyperandrogenemia in PCOS -- In Vivo Observations -- In Vitro Observations -- Insulin Signaling in Physiological Conditions -- Metabolic Pathway Anomalies -- Mitogenic Pathway Anomalies -- Lipotoxicity in PCOS -- Evidence of Lipid Metabolism Dysfunction in PCOS -- Adipose Tissue Depot in Women with PCOS -- Impact of Lipotoxicity on Androgenesis -- Directs and Indirect Effects of Thiazolidinediones on Androgenesis -- Summary -- References -- 9: Obesity, Dysmetabolic and Proinflammatory Milieu of Polycystic Ovary Syndrome -- Introduction -- Definition of Obesity and Body Fat Distribution -- Prevalence of Obesity -- Adipose Tissue Anatomy -- Adipose Tissue Metabolism -- Dietary Fat Absorption -- Energy Storage and Utilization -- Adipose Tissue as an Endocrine and Immunological Organ -- Steroid Hormone Peripheral Conversion: Role of Adipose Tissue -- Adipokine Function -- Development of Obesity -- Medical Disorders Associated with Obesity -- Metabolic Dysfunction in PCOS: Prevalence, Pattern, and Health Risks -- Impact of Metabolic Dysfunction on Ovarian Dysfunction in PCOS -- Impact of Obesity on PCOS -- Perpetuation of Signs and Symptoms of the Disorder -- PCOS with Superimposed Obesity -- Obesity-Induced PCOS -- Perpetuation of Medical Risks of Metabolic Dysfunction in PCOS -- Metabolic Inflammation in PCOS -- Obesity-Related Inflammation -- Chronic Low-Grade Inflammation in PCOS -- Nutrient-Induced Inflammation in PCOS -- Upregulation of the NFκB Inflammation Pathway. Upregulation of Atherothrombotic Inflammation Pathways -- Link to β-Cell Dysfunction -- Proinflammatory Impact of Excess Abdominal Fat -- Link Between Inflammation and Hyperandrogenism -- Hyperandrogenism as an Inducer of Inflammation -- Hyperandrogenism as a Suppressor of Inflammation when Obesity Is Present -- No Effect of Hyperandrogenism on Inflammation when Obesity Is Absent -- Inflammation as an Inducer of Hyperandrogenism -- Summary -- References -- Part III: Management of Polycystic Ovary Syndrome -- 10: Managing PCOS in the Adolescent -- Patient-Centered Approach to Treatment -- Hormonal Contraceptive Approach -- Metformin -- Combining COCPs and Metformin -- Anti-androgens -- Lifestyle -- Additional Therapies -- Summary -- References -- 11: Managing the PCOS-Related Symptoms of Hirsutism, Acne, and Female Pattern Hair Loss -- Introduction -- Clinical Hyperandrogenism -- Hirsutism -- Evaluation of Hirsutism -- History -- Physical Exam -- Biochemical Evaluation of Androgen Excess -- Treatment of Hirsutism -- Pharmacotherapy for Managing Hirsutism -- Systemic Treatments for Hirsutism -- Combined Hormonal Contraceptives -- Antiandrogens -- GnRH Analogues -- Glucocorticoids -- Insulin-Sensitizing Agents -- Topical Treatment for Hirsutism -- Eflornithine Hydrochloride -- Cosmetic Strategies for Managing Hirsutism -- Temporary Measures -- Permanent Measures -- Acne -- Evaluation of Acne -- Acne Treatments -- Systemic Treatments for Acne -- Combined Hormonal Contraceptives -- Oral Antibiotics -- Retinoids -- Antiandrogens -- Topical Treatments for Acne -- Cosmetic Strategies for Managing Acne -- Female Pattern Hair Loss -- Evaluation of Hair Loss -- Treatment of Female Pattern Hair Loss -- Systemic Treatments for Female Pattern Hair Loss -- Oral Antiandrogens -- Topical Treatment for Female Pattern Hair Loss. Cosmetic Strategies for Managing Hair Loss -- References -- 12: Role of Insulin-Sensitizing Drugs in PCOS Management -- Polycystic Ovary Syndrome and Insulin Resistance -- Insulin-Sensitizing Drugs: Background -- Clinical Use of ISDs in PCOS Management -- Summary and Implications for Practice -- References -- 13: Role of Statins and Resveratrol in PCOS Management -- Introduction -- Statins -- Mechanisms of Action of Statins -- In Vitro Studies of Statins -- Clinical Studies of Statins -- Limitations of the Use of Statins -- Statins - Future Directions -- Resveratrol -- Mechanism of Action of Resveratrol -- In Vitro Studies of Resveratrol -- In Vivo and Clinical Studies of Resveratrol -- Limitations of the Use of Resveratrol -- Resveratrol - Future Directions -- Conclusions -- References -- 14: Role of Lifestyle, Diet, and Exercise in the Management of Polycystic Ovarian Syndrome -- Introduction -- Why Diet Makes a Difference in Women with PCOS -- Dietary Carbohydrates -- Glycemic Index of Foods -- Limitations of Using the Glycemic Index for PCOS Patients -- Guidelines for Dietary Carbohydrate -- Fruits and PCOS -- Vegetables and PCOS -- Dietary Fiber and PCOS -- Recommendations for Fiber and PCOS -- Protein -- Lipid Abnormalities in PCOS and Relevance of Dietary Fat -- Dietary Fat and PCOS -- Dietary Calcium -- Vitamin D and PCOS -- Dietary Sodium and PCOS -- Defining Obesity, Overweight, and Normal Body Weight -- Caloric Needs and PCOS -- Behavior Modification in PCOS Management -- Snacking and Optimal Meal Patterns -- Importance of Exercise for PCOS Management -- Putting It All Together -- Sample Menu Plans for PCOS -- Exercise Recommendations -- Summary -- References -- Part IV: Management of Polycystic Ovary Syndrome Related Infertility -- 15: Managing PCOS-Related Infertility: Ovulation Induction, In Vitro Fertilization, and In Vitro Maturation. Introduction. |
| Record Nr. | UNINA-9910561293203321 |
| Cham, Switzerland : , : Springer, , [2022] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Polycystic Ovary Syndrome [[electronic resource] ] : Current and Emerging Concepts / / edited by Lubna Pal
| Polycystic Ovary Syndrome [[electronic resource] ] : Current and Emerging Concepts / / edited by Lubna Pal |
| Edizione | [1st ed. 2014.] |
| Pubbl/distr/stampa | New York, NY : , : Springer New York : , : Imprint : Springer, , 2014 |
| Descrizione fisica | 1 online resource (346 p.) |
| Disciplina |
610
612.6 616.4 618.1 |
| Soggetto topico |
Reproductive medicine
Gynecology Endocrinology Reproductive Medicine Gynecology Endocrinology |
| ISBN | 1-4614-8394-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Part I: Diagnostic Criteria and Epidemiology of PCOS -- Diagnostic Criteria and Epidemiology of PCOS -- Polycystic Ovarian Syndrome: A Diagnosis of Exclusion -- Part II: Pathophysiology of PCOS -- Recent Advances in the Genetics of Polycystic Ovary Syndrome -- Ovarian Dysfunction in Polycystic Ovary Syndrome -- The Role of the Adrenal Glands in the Hyperandrogenism Associated with Polycystic Ovarian Syndrome -- The Hypothalamic-Pituitary Axis in PCOS -- Insulin Resistance and Lipotoxicity in PCOS: Causes and Consequences -- Obesity, Metabolic Dysfunction, and Inflammation in Polycystic Ovary Syndrome -- Part III: Managing PCOS -- Role of Lifestyle and Diet in the Management of Polycystic Ovarian Syndrome -- Role of Insulin-Sensitizing Drugs in PCOS Management -- Role of Statins in PCOS Management -- Managing PCOS-Related Infertility: Ovulation Induction, In Vitro Fertilization, and In Vitro Maturation -- Managing the PCOS-Related Symptoms of Hirsutism, Acne, and Hair Loss -- Part IV: Unique Considerations in PCOS -- PCOS in Adolescence: Diagnostic Dilemmas and Management Considerations -- Considerations and Challenges for Pregnancy in Polycystic Ovary Syndrome -- Part V: Role of Surgery in PCOS Management -- Role of Surgery in the Management of PCOS: Rationale and Considerations for Bariatric Surgery -- Surgical Management of Polycystic Ovary Syndrome: A Contemporary Viewpoint on Place of Ovarian Surgery in PCOS Management -- Part VI: Recognized Risks and Emerging Concepts -- Long-Term Morbidity: Cardiovascular Disease, Cancer, and Depression in PCOS -- Emerging Concepts: Role of Vitamin D Deficiency in the Pathogenesis of PCOS. |
| Record Nr. | UNINA-9910300085003321 |
| New York, NY : , : Springer New York : , : Imprint : Springer, , 2014 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Speroff's clinical gynecologic endocrinology and infertility / / Hugh S. Taylor, Lubna Pal, Emre Seli
| Speroff's clinical gynecologic endocrinology and infertility / / Hugh S. Taylor, Lubna Pal, Emre Seli |
| Autore | Taylor Hugh S. |
| Edizione | [Ninth edition.] |
| Pubbl/distr/stampa | Philadelphia, Pennsylvania : , : Wolters Kluwer, , [2020] |
| Descrizione fisica | 1 online resource (2,579 pages) : illustrations |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-4963-5075-8
1-4963-5074-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Clinical gynecologic endocrinology and infertility |
| Record Nr. | UNINA-9910511476803321 |
Taylor Hugh S.
|
||
| Philadelphia, Pennsylvania : , : Wolters Kluwer, , [2020] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Speroff's clinical gynecologic endocrinology and infertility [[electronic resource] /] / Hugh S. Taylor, Lubna Pal, Emre Seli
| Speroff's clinical gynecologic endocrinology and infertility [[electronic resource] /] / Hugh S. Taylor, Lubna Pal, Emre Seli |
| Autore | Taylor Hugh S |
| Edizione | [9th ed.] |
| Pubbl/distr/stampa | Philadelphia, : Wolters Kluwer, [2020] |
| Descrizione fisica | 1 online resource (2,579 pages) : illustrations |
| Disciplina | 618.1 |
| Altri autori (Persone) |
FritzMarc A
PalLubna SeliEmre |
| Soggetto topico |
Genitalia, Female - physiology
Fertility - physiology Genital Diseases, Female Endocrine System Diseases Contraception Reproductive Techniques, Assisted Generative organs, Female - Diseases Generative organs, Female - Physiology |
| ISBN |
1-4963-5075-8
1-4963-5074-X 9781451189766 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Clinical gynecologic endocrinology and infertility |
| Record Nr. | UNINA-9910794000503321 |
|
Taylor Hugh S
|
||
| Philadelphia, : Wolters Kluwer, [2020] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Speroff's clinical gynecologic endocrinology and infertility [[electronic resource] /] / Hugh S. Taylor, Lubna Pal, Emre Seli
| Speroff's clinical gynecologic endocrinology and infertility [[electronic resource] /] / Hugh S. Taylor, Lubna Pal, Emre Seli |
| Autore | Taylor Hugh S |
| Edizione | [9th ed.] |
| Pubbl/distr/stampa | Philadelphia, : Wolters Kluwer, [2020] |
| Descrizione fisica | 1 online resource (2,579 pages) : illustrations |
| Disciplina | 618.1 |
| Altri autori (Persone) |
FritzMarc A
PalLubna SeliEmre |
| Soggetto topico |
Genitalia, Female - physiology
Fertility - physiology Genital Diseases, Female Endocrine System Diseases Contraception Reproductive Techniques, Assisted Generative organs, Female - Diseases Generative organs, Female - Physiology |
| ISBN |
1-4963-5075-8
1-4963-5074-X 9781451189766 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Clinical gynecologic endocrinology and infertility |
| Record Nr. | UNINA-9910813946303321 |
|
Taylor Hugh S
|
||
| Philadelphia, : Wolters Kluwer, [2020] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||